July 20, 2023 02:46 PM EDT
Pharma
Law

Pfiz­er set­tles trade se­crets case with com­pa­ny found­ed by ex-em­ploy­ees

Paul Schloesser

Associate Editor

Af­ter Pfiz­er sued a biotech found­ed by its for­mer em­ploy­ees and ac­cused them of mis­ap­pro­pri­at­ing trade se­crets and breach­ing con­tract last year, the com­pa­nies have …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

A service from the Financial Times